BOSTON SCIENTIFIC CORPORATION Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
BOSTON SCIENTIFIC CORPORATION (BSX) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $207.00 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-02-17
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $207.00M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $186.00M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $154.00M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $136.00M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed |
|---|---|---|
| 2025-12-31 | $207.00M 10-K · filed 2026-02-17 | |
| 2024-12-31 | $186.00M 10-K · filed 2026-02-17 | |
| 2023-12-31 | $154.00M 10-K · filed 2025-02-18 | |
| 2022-12-31 | $136.00M 10-K · filed 2024-02-20 | |
| 2021-12-31 | $130.00M 10-K · filed 2023-02-23 | |
| 2020-12-31 | $134.00M 10-K · filed 2022-02-23 | |
| 2019-12-31 | $121.00M 10-K · filed 2021-02-23 | |
| 2018-12-31 | $106.00M 10-K · filed 2020-02-25 | |
| 2017-12-31 | $104.00M 10-K · filed 2019-02-19 | |
| 2016-12-31 | $142.00M 10-K · filed 2018-02-20 | |
| 2015-12-31 | $138.00M 10-K · filed 2017-02-23 | |
| 2014-12-31 | $150.00M 10-K · filed 2016-02-24 | |
| 2013-12-31 | $143.00M 10-K · filed 2015-02-25 | |
| 2012-12-31 | $171.00M 10-K · filed 2014-02-26 | |
| 2011-12-31 | $219.00M 8-K · filed 2013-05-29 | |
| 2010-12-31 | $155.00M 10-K · filed 2012-02-17 | $90.00M 10-K · filed 2011-02-17 |
| 2009-12-31 | $92.00M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |